Freeline Therapeutics

NASDAQ: FRLN · Real-Time Price · USD
6.49
0.01 (0.15%)
At close: Feb 16, 2024, 8:37 PM

Freeline Therapeutics Revenue

Freeline Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending September 30, 2023, Freeline Therapeutics generated $5K in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
152
Market Cap
28.28M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.